Susquehanna International Group’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
SCM
RA
AWA
KCM
EIM
Susquehanna International Group's SOPH Position: Q1 2026 in Review
Susquehanna International Group reduced its SOPHiA GENETICS (SOPH) stake by 57% in Q1 2026, selling an estimated $84.4K and leaving 13,156 shares worth $65.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12545.
Susquehanna International Group first reported a position in SOPH in Q4 2024 and has held it in 4 quarters since. The position peaked at $142K in Q4 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.
- Susquehanna International Group held 13,156 shares of SOPHiA GENETICS worth $65.1K as of Q1 2026.
- Susquehanna International Group sold 17,355 SOPHiA GENETICS shares in Q1 2026, an estimated $84.4K.
- SOPHiA GENETICS made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12545 holding.
- Susquehanna International Group first reported a position in SOPHiA GENETICS in Q4 2024 and has held it in 4 quarters since.
- Susquehanna International Group's SOPHiA GENETICS position peaked at $142K in Q4 2025.
- 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.